Convallaer Pharmaceuticals Private Limited
About Convallaer Pharmaceuticals Private Limited
Data last updated:
Convallaer Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the repair services segment of the electronics sector. It was incorporated on 04 May 2022.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U52602UP2022PTC163549.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Saroj Katiyar and Tanushree Katiyar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 112/369 Swaroop Nagar, Kanpur, Uttar Pradesh, India – 208002.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.1 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹2.3 Cr (net margin 28.3%) and EBITDA of ₹3.25 Cr (EBITDA margin 40.1%).
As per MCA filings, the company has open charges of ₹4.98 Cr on record.
Company details
Contact details
Convallaer Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh.
- Registered Address112/369 Swaroop Nagar, Kanpur, Uttar Pradesh, India – 208002
- IndustryElectrnoics, Repair Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Convallaer Pharmaceuticals are trade and hospital and medical care. In detail, this covers retail trading and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Convallaer Pharmaceuticals Private Limited, buy the company report.
Financials of Convallaer Pharmaceuticals Private Limited
FY 2025 filings availableConvallaer Pharmaceuticals Private Limited reported revenue of ₹8.1 Cr (up 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 36% in the latest year. EBITDA rose 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹3.25 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹2.3 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 40.1% | |
| Net Profit Margin | 28.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Convallaer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Convallaer Pharmaceuticals Private Limited
Convallaer Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saroj Katiyar | Director | 04 May 2022 | 4 Years 6 Months | Current |
| Tanushree Katiyar Also directs: Katiyar Chest Centre Private Limited | Director | 04 May 2022 | 4 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Dec 2023 | 100879225 | Axis Bank Limited | ₹4.98 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Convallaer Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Convallaer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Convallaer Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Convallaer Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Saroj Katiyar was appointed as Director on 04 May 2022.
Frequently asked questions
Convallaer Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in repair services, within the electronics industry. It was incorporated on 04 May 2022 (4+ years old) and is registered under CIN U52602UP2022PTC163549.
Convallaer Pharmaceuticals has 2 current directors:
- Saroj Katiyar - Director
- Tanushree Katiyar - Director
The latest financial statements of Convallaer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Convallaer Pharmaceuticals is U52602UP2022PTC163549. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Convallaer Pharmaceuticals was incorporated on 04 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kanpur.
Saroj Katiyar was appointed as Director on 04 May 2022. Tanushree Katiyar was appointed as Director on 04 May 2022.
The registered office of Convallaer Pharmaceuticals is at 112369 Swaroop Nagar, Kanpur, Uttar Pradesh, India – 208002.
Convallaer Pharmaceuticals operates in the electronics industry, in the repair services segment.
Convallaer Pharmaceuticals has open charges of ₹4.98 Cr and no satisfied charges on record as per latest MCA filings.
Convallaer Pharmaceuticals can be reached at its registered office: 112369 Swaroop Nagar, Kanpur, Uttar Pradesh, India – 208002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
